TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Grip Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-Free Survival at 24 Weeks
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of reflux gastritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Dose-adjusted steady-state concentration of remimazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance dose of remimazolam for maintaining general anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total dose of remimazolam used to induce general anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean Daytime BP Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early operative morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Change in participants' physical reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in percentage of participants' mouse click accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of SUPPORT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Digits Span backward performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Leeds Assessment of Neuropathic Symptoms and Signs Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Anxiety levels measured by STAI Form TX I
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety levels measured by STAI Form TX II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PE diagnosis accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ability to assess perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of peripartum blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Urine sulforaphane
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urine sulforaphane metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma sulforaphane
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma sulforaphane metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stool sample based gut microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enrollment proportion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Short-term, intermediate, and long-term retention in care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Clinical
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean standardized uptake value (SUV) in the heart
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in pain intensity from baseline to 1 week after the intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance of the effect on pain from 1 week to 3 months after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ipsilateral breast cancer recurrence (IBTR)
Endpoint domain: Mortality/survival
Primary endpoint: Number of treatment-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with identified pathogenic variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level spread of each volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-168h of cagrilintide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of cagrilintide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-168h of semaglutide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venham Anxiety and Behavioral Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Salivary cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Depth or grade of transmural healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of Participants Achieving >= 30% Improvement in JIA-ACR 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Patients With at Least One COVID-19-related Medically Attended Contact Due to Increased COVID-19 Symptom Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With at Least One COVID-19-related Medically Attended Contact Due to Death (All-cause Mortality)
Endpoint domain: Mortality/survival
Primary endpoint: Communication Function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Students' knowledge level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Functional assessment of stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Aberrant Wound Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from baseline of hematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduced opiate use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in children's pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interleukin-6 levels in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Medical treatment events
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Composite Autonomic Symptom Score (COMPASS 31)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of minimal residual disease (MRD) negative status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Annualized relapse rate (ARR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention Rate of Fissure Sealants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Kyphosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soleus H-reflex latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Anxiety levels as measured by HADS-A
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Unit Healing Time index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: observance to the physical activity program
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-diagnosis with ADHD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of total goals achieved
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Overall GAS score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Monthly average of daily step count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of gingival bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Area Under the Curve (AUC0-tau;ss) of total IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD4 recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: [6,6-2H2]glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Adverse Events related to the treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Dose Limiting Toxicities (DLTs) at each dose level
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Diabetes Distress Scale (DDS) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bone defect width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with complete response in Total Fric Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with complete response in critical temperature threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with itch numerical rating scale =0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to post exposure prophylaxis treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the standard score of the Vineland Adaptive Behavior Scales - Third Edition Adaptive Behavior Composite
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percent weight change in parents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BMI z-score in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Success of Implantation of LAAC device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Attendance at 6-month follow-up visit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dose-limiting Toxicity (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Fidelity to LPV
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: overall gastrointestinal discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sitting Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstruation pad leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nurse Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of Severe Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of ABBV-525
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Dose Limiting Toxicity (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Concentration-time Curve (AUC) From Zero to the Last Quantifiable Concentrations (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Area of Hyperalgesia (cm^2) Post-capsaicin Injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast milk calories (kcal/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Breast milk fat (g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Breast milk protein (g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Breast milk carbohydrate (g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Breast milk volume (mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Burnout assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Identification of structural heart disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 10-meters walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk Control Measurement scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical and diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of maternal-fetal infections
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of proven maternal bacterial infections
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of proven and probable early neonatal infections
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Assessed by Pain Numeric Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid Medication Usage Assessed by Frequency of Use Log
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Non-opioid Pain Medication Usage Assessed by Frequency of Use Log
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Composite of all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Any stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Active Extension Deficits (AED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of Ambu aScope gastro
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ability and time to achieve target temperature and ease of maintaining temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects in each response category
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in objective Performance Agency Task (TMS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in subjective Performance Agency Task (TMS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in objective Performance Agency Task (MBSR)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in subjective Performance Agency Task (MBSR)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anxiety level according to BAI
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stress level according to mASS-14
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Genome wide expression profile of circulating cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Feasibility of magnetic-assisted colonoscope system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of magnetic-assisted colonoscope system
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in Controlled Attenuation Parameter (CAP) and Alanine Aminotransferase (ALT) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Decrease in Pediatric NAFLD Fibrosis Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Incidence of brady arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Predictors of development of late onset heart block needing pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: New onset Atrial Fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brief Young Adult Alcohol Consequences Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the symptom numerical rating scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: End expiratory lung volume (EELV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent of participants who have a follow-up healthcare visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Behavioral Intentions for continued use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intensity of sensory attributes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of liking or disliking of sensations
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fecal microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessment using Lanss Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessment using Pain Detect Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessment using Numerical Pain Rating Scale (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of CLE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usable blastocyst formation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in performance on the Oxford Multiple Errands Test (OxMET-NL)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: modified ashworth scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ABILHAND-KID
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Manual Ability Classification scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Walking perimeter changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early diagnosis of schistosomal bladder cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Neonatal severe infection/sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: Resistant bacterial colonisation over time
Endpoint domain: Adverse events/effects
Primary endpoint: Time to prosthesis reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of Time in Range (TIR 70 to 180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: State Trait Anxiety Inventory (STAI) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AUC(0-inf) of EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-inf) of LNG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change from baseline in fasting triglycerides (TG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change Readiness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physician global assessment of disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient/parent global assessment of overall well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall exercise capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nociception Level Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Transient Neurologic Deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of permanent Neurologic Deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean Maximum Standard Uptake Value (SUVmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median SUVmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Progressed by Prostate-specific Antigen (PSA) Response Group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and technical feasibility of microdevice insertion/removal
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy across all individual agents or drug combinations
Endpoint domain: Physiological/clinical
Primary endpoint: Impact of Movement Disorders on Health-Related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Concentration of plasma inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum Pre-Albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: White blood cell count (WBC, cells/μL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Erythrocyte sedimentation rate (ESR, mm/hour)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-reactive Protein (CRP, mg/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased HPV vaccination rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Subjective Pain Ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences in Pain Tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences in Pain Onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes